SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-07
👔
ORAGENICS INC
@OGEN_InsiderForm 4 Filing: Spencer John Acquires (Grant) shares of $OGEN
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
ORAGENICS INC
Ticker: $OGEN
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-01
Shares: 55,900
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Spencer John, holds the title of Chief Financial Officer at ORAGENICS INC.
On 2026-07-01, the insider transacted 55,900 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Spencer John (Chief Financial Officer) was granted $0 of $OGEN
Post-Transaction Position: 55,900 shares
SEC Accession No: 0002144116-26-000005 (CIK: 2144116)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.